Stephen Basso
CIK 1815707 · Chief Financial Officer · last filed 2026-05-22
Stephen Basso is a Chief Financial Officer who has filed 15 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing, for INVA, was dated May 22, 2026. Current disclosed insider exposure totals $2.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.01M
2
15
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| INVA | Chief Financial Officer | 88,571 | $22.74 | $2.01M | $0 | 11 | 2026-05-22 |
| Inozyme Pharma, Inc. (INZY) Delisted | SVP Finance (PFO) | — | $4.00 | — | $0 | 4 | 2021-03-25 |
Recent Filings
15 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-22 | INVA | Mixed | +564 | -$12.4K | EDGAR |
| 2026-05-06 | INVA | Grant (A) | +37,994 | $0 | EDGAR |
| 2026-02-24 | INVA | Tax (F) | −1,244 | -$29.1K | EDGAR |
| 2025-11-24 | INVA | Mixed | +367 | -$5.0K | EDGAR |
| 2025-11-05 | INVA | Grant (A) | +27,609 | $500.0K | EDGAR |
| 2025-08-22 | INVA | Tax (F) | −237 | -$4.7K | EDGAR |
| 2025-05-22 | INVA | Mixed | +1,116 | -$4.5K | EDGAR |
| 2025-03-26 | INVA | Grant (A) | +10,569 | $191.1K | EDGAR |
| 2025-02-24 | INVA | Mixed | −263 | -$20.0K | EDGAR |
| 2024-03-07 | INVA | Grant (A) | +12,096 | $180.0K | EDGAR |